Nanomaterial-based sensors for detection of disease by volatile organic compounds

Nanomedicine

Volumn 8, Issue 5, 2013, Pages 785-806

  Broza, Yoav Y ^a   Haick, Hossam ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

blood; breath; cell; crossreactive; disease diagnosis; nanomaterial; selective; sensor; skin; volatile organic compound

Indexed keywords

ACETONE; AMMONIA; HYDROGEN PEROXIDE; NANOMATERIAL; NITRIC OXIDE; SINGLE WALLED NANOTUBE; VOLATILE ORGANIC COMPOUND;

COLORIMETRY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST; HUMAN; METABOLITE; NANOARRAY; NANOFABRICATION; NANOSENSOR; NONHUMAN; PIEZOELECTRICITY; PRIORITY JOURNAL; REVIEW; SURFACE ACOUSTIC WAVE SENSOR; TRANSDUCER;

EID: 84877666767     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.64     Document Type: Review

References (138)

1. WHO. The Global Status Report on Noncommunicable Diseases. WHO, Geneva, Switzerland (2010).
2. Kuhn M, Goebel W, Philpott DJ, Sansonetti PJ. Overview of the bacterial pathogens. In: Immunology of Infectious Diseases. Kaufmann SHE, Sher A, Ahmed R (Eds). ASM Press, WA, USA, 5-24 (2002).
3. WHO. Communicable Disease Alert and Response for Mass Gatherings: Key Considerations. WHO, Geneva, Switzerland (2008).
4. Cokkinides VE, Bandi P, Siegel RL, Jemal A. Cancer-related risk factors and preventive measures in US hispanics/latinos. CA Cancer J. Clin. 62(6), 353-363 (2012).
5. Karnon J, Goyder E, Tappenden P et al. A review and critique of modelling in prioritising and designing screening programmes. Health Techn. Assess. 11, 1-145 (2007).
6. Hakim M, Broza YY, Barash O et al. Volatile organic compounds of lung cancer and possible biochemical pathways. Chem. Rev. 112, 5949-5966 (2012).
7. Boots AW, van Berkel JJ, Dallinga JW, Smolinska A, Wouters EF, van Schooten FJ. The versatile use of exhaled volatile organic compounds in human health and disease. J. Breath Res. 6(2), 027108 (2012).
8. Shirasu M, Touhara K. The scent of disease: volatile organic compounds of the human body related to disease and disorder. J. Biochem. 150, 257-266 (2011).
9. Tisch U, Haick H. Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing. Rev. Chem. Eng. 26, 171-179 (2010).
10. Tisch U, Billan S, Ilouze M, Phillips M, Peled N, Haick H. Volatile organic compounds in exhaled breath as biomarkers for the early detection and screening of lung cancer. CML Lung Cancer 5, 107-117 (2012).
11. Amann A, Ligor M, Ligor T et al. Analysis of exhaled breath for screening of lung cancer patients. MEMO 3, 106-112 (2010).
12. Turner AP, Magan N. Electronic noses and disease diagnostics. Nat. Rev. Microbiol. 2, 161-166 (2004).
13. Centerwall SA, Centerwall WR. The discovery of phenylketonuria: the story of a young couple, two retarded children, and a scientist. Pediatrics 105, 89-103 (2000).
14. Anderson JC, Babb AL, Hlastala MP. Modeling soluble gas exchange in the airways and alveoli. Ann. Biomed. Eng. 31, 1402-1422 (2003).
15. Kalliomaki PL, Korhonen O, Vaaranen V, Kalliomaki K, Koponen M. Lung retention and clearance of shipyard arc welders. Int. Arch. Occur. Environ. Health 42, 83-90 (1978).
16. Jakubowski M, Czerczak S. Calculating the retention of volatile organic compounds in the lung on the basis of their physicochemical properties. Environ. Toxicol. Pharmacol. 28, 311-315 (2009).
17. Corradi M, Mutti A. News from the Breath Analysis Summit 2011. J. Breath Res. 6(2), 020201 (2012).
18. Punyadeera C, van der Merwe MT, Crowther NJ et al. Weight-related differences in glucose metabolism and free fatty acid production in two South African population groups. Int. J. Obes. Relat. Metab. Disord. 25(8), 1196-1205 (2001).
19. Tisch U, Haick H. Nanomaterials for crossreactive sensor arrays. MRS Bull. 35, 797-803 (2010).
20. Bachar N, Mintz L, Zilberman Y et al. Polycyclic aromatic hydrocarbon for the detection of nonpolar analytes under counteracting humidity conditions. ACS Appl. Mater. Interf. 4, 4960-4965 (2012).
21. Konvalina G, Haick H. The effect of humidity on nanoparticle-based chemiresistors: a comparison between synthetic and real-world samples. ACS Appl. Mater. Interf. 4, 317-325 (2012).
22. Zilberman Y, Ionescu R, Feng X, Mullen K, Haick H. Nanoarray of polycyclic aromatic hydrocarbons and carbon nanotubes for accurate and predictive detection in real-world environmental humidity. ACS Nano 5, 6743-6753 (2011).
23. Zilberman Y, Tisch U, Shuster G et al. Carbon nanotube/hexa-peri- hexabenzocoronene bilayers for discrimination between nonpolar volatile organic compounds of cancer and humid atmospheres. Adv. Mater. 22, 4317-4320 (2010).
24. Peng G, Tisch U, Adams O et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat. Nanotechol. 4, 669-673 (2009).
25. Goepel W. Chemical sensing, molecular electronics and nanotechnology: interface technologies down to the molecular scale. Sens. Actuat. B 4, 7-21 (1991).
26. Madasamy T, Pandiaraj M, Balamurugan M et al. Virtual electrochemical nitric oxide analyzer using copper, zinc superoxide dismutase immobilized on carbon nanotubes in polypyrrole matrix. Talanta 100, 168-174 (2012).
27. Kuzmych O, Allen BL, Star A. Carbon nanotube sensors for exhaled breath components. Nanotechnology 18, 375502 (2007).
28. Gouma PI, Kalyanasundaram K. A selective nanosensing probe for nitric oxide. Appl. Phys. Lett. 93, 244102 (2008).
29. Ng SR, Guo CX, Li CM. Highly sensitive nitric oxide sensing using three-dimensional graphene/ionic liquid nanocomposite. Electroanalysis 23, 442-448 (2011).
30. Winlaw DS, Keogh AM, Schyvens CG, Spratt PM, Macdonald PS, Smythe GA. Increased nitric oxide production in heart failure. Lancet 344, 373-374 (1994).
31. Kao KW, Hsu MC, Chang YH, Gwo S, Yeh JA. A sub-ppm acetone gas sensor for diabetes detection using 10 nm thick ultrathin InN FETs. Sensors 12, 7157-7168 (2012).
32. Righettoni M, Tricoli A, Gass S, Schmid A, Amann A, Pratsinis SE. Breath acetone monitoring by portable Si:WO3 gas sensors. Anal. Chim. Acta 738, 69-75 (2012).
33. de Lacy Costello BP, Ewen RJ, Ratcliffe NM, Richards M. The characteristics of novel low-cost sensors for volatile biomarker detection. J. Breath Res. 2, 037017 (2008).
34. Novak BJ, Blake DR, Meinardi S et al. Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in Type 1 diabetes. Proc. Natl Acad. Sci. USA 104, 15613-15618 (2007).
35. Galassetti P, Novak B, Nemet D et al. Breath ethanol and acetone as indicators of serum glucose levels: an initial report. Diabetes Technol. Ther. 7, 115-123 (2005).
36. Gouma P, Kalyanasundaram K, Wang L, Yun X, Stanacevic M. Nanosensor and breath analyzer for ammonia detection in exhaled human breath. IEEE Sensors 10, 49-53 (2010).
37. Gouma P, Prasad A, Stanacevic S. A selective nanosensor device for exhaled breath analysis. J. Breath Res. 5, 037110 (2011).
38. Gu F, Yin X, Yu H, Wang P, Tong L. Polyaniline/polystyrene single-nanowire devices for highly selective optical detection of gas mixtures. Optics Express 17, 11230-11235 (2009).
39. Yebo NA, Sree SP, Levrau E et al. Selective and reversible ammonia gas detection with nanoporous film functionalized silicon photonic micro-ring resonator. Optics Express 20, 11855-11862 (2012).
40. Cheang HK, Rangecroft L, Plant ND, Morris AA. Hyperammonaemia due to Klebsiella infection in a neuropathic bladder. Pediatr. Nephrol. 12, 658-659 (1998).
41. Hunt JF, Erwin E, Palmer L. Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am. J. Respir. Crit. Care Med. 165, 101-107 (2002).
42. Simenhoff ML, Burke JF, Saukkonen JJ, Ordinario AT, Doty R. Biochemical profile or uremic breath. N. Engl. J. Med. 297, 132-135 (1977).
43. Tangerman A, Winkel EG. Extra-oral halitosis: an overview. J. Breath Res. 4, 017003 (2010).
44. Li SJ, Shi YF, Liu L, Song LX, Pang H, Du JM. Electrostatic self-assembly for preparation of sulfonated graphene/gold nanoparticle hybrids and their application for hydrogen peroxide sensing. Electrochim. Acta 85, 628-635 (2012).
45. Song MJ, Hwang SW, Whanga D. Non-enzymatic electrochemical CuO nanoflowers sensor for hydrogen peroxide detection. Talanta 80, 1648-1652 (2010).
46. Cao X, Wang N, Wang L, Mo C, Xu YJ, Lin G. A novel non-enzymatic hydrogen peroxide biosensor based on ultralong manganite MnOOH nanowires. Sens. Actuat. B 147, 730-734 (2010).
47. Yang MH, Qu F, Lu YS, Shen GL, Yu RQ. Platinum nanowire nanoelectrode array for the fabrication of biosensors. Biomaterials 27, 5944-5950 (2006).
48. Yang MH, Yang YH, Lu YS, Shen GL, Yu RQ. Platinum nanoparticles-doped sol-gel/carbon nanotubes composite electrochemical sensors and biosensors. Biosens. Bioelectron. 21, 1125-1131 (2006).
49. Zhou Y, Yu G, Chang F, Hu B, Zhong CJ. Gold-platinum alloy nanowires as highly sensitive materials for electrochemical detection of hydrogen peroxide. Anal. Chem. Acta 757, 56-62 (2012).
50. Anh DTV, Olthuis W, Bergveld P. A hydrogen peroxide sensor for exhaled breath measurement. Sens. Actuat. B 111-112, 494-499 (2005).
51. Kulys J. Flow-through amperometric sensor for hydrogen peroxide monitoring in gaseous media. Sens. Actuat. B 9, 143-147 (1992).
52. Wiedemair J, van Dorp HD, Olthuis W, van den Berg A. Developing an amperometric hydrogen peroxide sensor for an exhaled breath analysis system. Electrophoresis 33, 3181-3186 (2012).
53. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am. J. Respir. Crit. Care Med. 163, 1693-1722 (2001).
54. Mccurdy MR, Sharafkhaneh A, Abdel-Monem H, Rojo J, Tittel FK. Exhaled nitric oxide parameters and functional capacity in chronic obstructive pulmonary disease. J. Breath Res. 5, 016003 (2011).
55. Silva LI, Freitas AC, Rocha-Santos TA, Pereira ME, Duarte AC. Breath analysis by optical fiber sensor for the determination of exhaled organic compounds with a view to diagnostics. Talanta 83, 1586-1594 (2011).
56. Ruan H, Kang Y, Wang YX, Claus RO. Nanostructured fiber optic sensors for detection of volatile organic compounds in breath. Proc. SPIE 6083, 60830G (2006).
57. Liu C, Hayashi K, Toko K. Au nanoparticles decorated polyaniline nanofiber sensor for detecting volatile sulfur compounds in expired breath. Sens. Actuat. B 161, 504-509 (2012).
58. Rock F, Barsan N, Weimar U. Electronic nose: current status and future trends. Chem. Rev. 108, 705-725 (2008).
59. Thaler ER, Hanson CW. Medical applications of electronic nose technology. Expert Rev. Med. Dev. 2, 559-566 (2005).
60. Peng G, Trock E, Haick H. Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with non-polymeric organic materials. Nano Lett. 8, 3631-3635 (2008).
61. Peng G, Tisch U, Haick H. Detection of nonpolar molecules by means of carrier scattering in random networks of carbon nanotubes: toward diagnosis of diseases via breath samples. Nano Lett. 9, 1362-1368 (2009).
62. Lewis NS. Comparisons between mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detector. Acc. Chem. Res. 37, 663-672 (2004).
63. Dovgolevsky E, Konvalina G, Tisch U, Haick H. Monolayer-capped cubic platinum nanoparticles for sensing nonpolar analytes in highly humid atmospheres. J. Phys. Chem. C 114, 14042-14049 (2010).
64. Machado RF, Laskowski D, Deffenderfer O et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am. J. Respir. Crit. Care Med. 171, 1286-1291 (2005).
65. Peled N, Hakim M, Bunn PA Jr et al. Non-invasive breath analysis of pulmonary nodules. J. Thorac. Oncol. 7, 1528-1533 (2012).
66. Peng G, Hakim M, Broza YY et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br. J. Cancer 103, 542-551 (2010).
67. Hakim M, Billan S, Tisch U et al. Diagnosis of head and neck cancer from exhaled breath. Br. J. Cancer 104, 1649-1655 (2011).
68. Broza YY, Kremer R, Tisch U et al. A nanomaterial-based breath test for short-term follow-up after lung tumor resection. Nanomedicine 9(1), 15-21 (2012).
69. Barash O, Peled N, Hirsch FR, Haick H. Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles. Small 5, 2618-2624 (2009).
70. Barash O, Peled N, Tisch U, Bunn PA, Hirsch FR, Haick H. Classification of the lung cancer histology by gold nanoparticle sensors. Nanomedicine 8, 580-589 (2012).
71. Chapman EA, Thomas PS, Stone E, Lewis C, Yates DH. A breath test for malignant mesothelioma using an electronic nose. Eur. Respir. J. 40, 448-454 (2012).
72. Dragonieri S, van der Schee MP, Massaro T et al. An electronic nose distinguishes exhaled breath of patients with malignant pleural mesothelioma from controls. Lung Cancer 75, 326-331 (2012).
73. Xu ZQ, Broza YY, Ionsecu R et al. A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions. Br. J. Cancer 108(4), 941-950 (2012).
74. Timms C, Thomas PS, Yates DH. Detection of gastro-oesophageal reflux disease (GORD) in patients with obstructive lung disease using exhaled breath profiling. J. Breath Res. 6, 016003 (2012).
75. Ionescu R, Broza Y, Shaltieli H et al. Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes. ACS Chem. Neurosci. 2, 687-693 (2011).
76. Tisch U, Schlesinger I, Ionescu R et al. Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors. Nanomedicine (Lond.) 8(1), 43-56 (2013).
77. Haick H, Hakim M, Patrascu M et al. Sniffing chronic renal failure in rat model by an array of random networks of single-walled carbon nanotubes. ACS Nano 3, 1258-1266 (2009).
78. Marom O, Nakhoul F, Tisch U, Shiban A, Abassi Z, Haick H. Gold nanoparticle sensors for detecting chronic kidney disease and disease progression. Nanomedicine (Lond.) 7(5), 639-650 (2012).
79. Shykhon ME, Morgan DW, Dutta R, Hines EL, Gardner JW. Clinical evaluation of the electronic nose in the diagnosis of ear, nose and throat infection: a preliminary study. J. Laryngol. Otol. 118, 706-709 (2004).
80. Dutta R, Hines EL, Gardner JW, Boilot P. Bacteria classification using Cyranose 320 electronic nose. Biomed. Eng. Online 1, 4 (2002).
81. Peled N, Ionescu R, Nol P et al. Detection of volatile organic compounds in cattle naturally infected with Mycobacterium bovis. Sens. Actuat. B 171, 588-594 (2012).
82. Yates JW, Chappell MJ, Gardner JW et al. Data reduction in headspace analysis of blood and urine samples for robust bacterial identification. Comput. Methods Programs Biomed. 79, 259-271 (2005).
83. Janzen MC, Ponder JB, Bailey DP, Ingison CK, Suslick KS. Colorimetric sensor arrays for volatile organic compounds. Anal. Chem. 78, 3591-3600 (2006).
84. Suslick KS. An optoelectronic nose: "seeing" smells by means of colorimetric sensor arrays. MRS Bull. 29, 720-725 (2004).
85. Lim SH, Feng L, Kemling JW, Musto CJ, Suslick KS. An optoelectronic nose for the detection of toxic gases. Nat. Chem. 1, 562-567 (2009).
86. Feng L, Musto CJ, Kemling JW, Lim SH, Zhong W, Suslick KS. Colorimetric sensor array for determination and identification of toxic industrial chemicals. Anal. Chem. 82, 9433-9440 (2010).
87. Mazzone PJ, Wang XF, Xu Y et al. Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J. Thorac. Oncol. 7, 137-142 (2011).
88. Carey JR, Susick KS, Hulkower KI et al. Rapid identification of bacteria with a disposable colorimetric sensing array. J. Am. Chem. Soc. 133, 7571-7576 (2011).
89. Matsuguchi M, Uno T. Molecular imprinting strategy for solvent molecules and its application for QCM-based VOC vapor sensing. Sens. Actuat. B 113, 94-99 (2006).
90. D'Amico A, Penazza G, Santonico M et al. An investigation on electronic nose diagnosis of lung cancer. Lung Cancer 68, 170-176 (2010).
91. Di Natale C, Macagnano A, Martinelli E et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens. Bioelectron. 18, 1209-1218 (2003).
92. D'Amico A, Bono R, Pennazza G et al. Identification of melanoma with a gas sensor array. Skin Res. Technol. 14, 226-236 (2008).
93. Pennazza G, Santonico M, Martinelli E et al. Monitoring of melanoma released volatile compounds by a gas sensors array: from in vitro to in vivo experiments. Sens. Actuat. B 154, 288-294 (2011).
94. Montuschi P, Santonico M, Mondino C et al. Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. Chest 137, 790-796 (2010).
95. Incalzi RA, Pennazza G, Scarlata S et al. Reproducibility and respiratory function correlates of exhaled breath fingerprint in chronic obstructive pulmonary disease. PLoS One 7, e45396 (2012).
96. Pennazza G, Marchetti E, Santonico M et al. Application of a quartz microbalance based gas sensor array for the study of halitosis. J. Breath Res. 2, 017009 (2008).
97. Jakubik WP. Surface acoustic wave-based gas sensors. Thin Solid Films 520, 986-993 (2011).
98. Chen X, Cao M, Hu W, Wang P, Ying K, Pan H. A study of an electronic nose for detection of lung cancer based on a virtual SAW gas sensors aray and imaging recognition method. Meas. Sci. Technol. 16, 1535-1546 (2005).
99. Phillips M, Basa-Dalay V, Blais J et al. Point-of-care breath test for biomarkers of active pulmonary tuberculosis. Tuberculosis 92, 314-320 (2012).
100. Phillips M, Cataneo RN, Saunders C, Hope P, Schmitt P, Wai J. Volatile biomarkers in the breath of women with breast cancer. J. Breath. Res. 4, 026003 (2010).
101. Xue R, Dong L, Zhang S et al. Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 22, 1181-1186 (2008).
102. Amal H, Ding L, Liu BB et al. The scent fingerprint of hepatocarcinoma: in vitro metastasis prediction with volatile organic compounds (VOCs). Int. J. Nanomedicine 7, 4135-4146 (2012).
103. Tisch U, Aluf Y, Ionescu R et al. Detection of asymptomatic nigrostriatal Dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors. ACS Chem. Neurosci. 3, 161-166 (2011).
104. Lee J, Ngo J, Blake D et al. Improved predictive models for plasma glucose estimation from multi-linear regression analysis of exhaled volatile organic compounds. J. Appl. Physiol. 107, 155-160 (2009).
105. Smith AJ, Strang LB. An inborn error of metabolism with the urinary excretion of alpha-hydroxy-butyric acid and phenylpyruvic acid. Arch. Dis. Child 33, 109-113 (1958).
106. Chamberlin ME, Ubagai T, Mudd SH, Wilson WG, Leonard JV, Chou JY. Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency. J. Clin. Invest. 98, 1021-1027 (1996).
107. Gahl WA, Bernardini I, Finkelstein JD et al. Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency. J. Clin. Invest. 81, 390-397 (1988).
108. Humbert JA, Hammond KB, Hathaway WE. Trimethylaminuria: the fish-odour syndrome. Lancet 2, 770-771 (1970).
109. Zschocke J, Kohlmueller D, Quak E, Meissner T, Hoffmann GF, Mayatepek E. Mild trimethylaminuria caused by common variants in FMO3 gene. Lancet 354, 834-835 (1999).
110. Olopade CO, Zakkar M, Swedler WI, Rubinstein I. Exhaled pentane levels in acute asthma. Chest 111, 862-865 (1997).
111. Paredi P, Kharitonov SA, Barnes PJ. Elevation of exhaled ethane concentration in asthma. Am. J. Respir. Crit. Care Med. 162, 1450-1454 (2000).
112. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am. J. Respir. Crit. Care Med. 160, 216-220 (1999).
113. Ashutosh K. Nitric oxide and asthma: a review. Curr. Opin. Pulm. Med. 6, 21-25 (2000).
114. van Berkel JJ, Dallinga JW, Moller GM et al. Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air. J. Chromatogr. B 861, 101-107 (2008).
115. Kanoh S, Kobayashi H, Motoyoshi K. Exhaled ethane: an in vivo biomarker of lipid peroxidation in interstitial lung diseases. Chest 128, 2387-2392 (2005).
116. Kokoszka J, Nelson RL, Swedler WI, Skosey J, Abcarian H. Determination of inflammatory bowel disease activity by breath pentane analysis. Dis. Colon Rectum 36, 597-601 (1993).
117. Pelli MA, Trovarelli G, Capodicasa E, De Medio GE, Bassotti G. Breath alkanes determination in ulcerative colitis and Crohn's disease. Dis. Colon Rectum 42, 71-76 (1999).
118. Goldberg EM, Blendis LM, Sandler S. A gas chromatographic - mass spectrometric study of profiles of volatile metabolites in hepatic encephalopathy. J. Chromatogr. 226, 291-299 (1981).
119. Chen S, Zieve L, Mahadevan V. Mercaptans and dimethyl sulfide in the breath of patients with cirrhosis of the liver. Effect of feeding methionine. J. Lab. Clin. Med. 75, 628-635 (1970).
120. Kaji H, Hisamura M, Saito N, Murao M. Gas chromatographic determination of volatile sulfur compounds in the expired alveolar air in hepatopathic subjects. J. Chromatogr. 145, 464-468 (1978).
121. Phillips M, Sabas M, Greenberg J. Increased pentane and carbon disulfide in the breath of patients with schizophrenia. J. Clin. Pathol. 46, 861-864 (1993).
122. Mostafa MH, Helmi S, Badawi AF, Tricker AR, Spiegelhalder B, Preussmann R. Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients. Carcinogenesis 15, 619-625 (1994).
123. Garner CE, Smith S, Bardhan PK, Ratcliffe NM, Probert CS. A pilot study of faecal volatile organic compounds in faeces from cholera patients in Bangladesh to determine their utility in disease diagnosis. Trans. R. Soc. Trop. Med. Hyg. 103, 1171-1173 (2009).
124. Le Marchand L, Wilkens LR, Harwood P, Cooney RV. Use of breath hydrogen and methane as markers of colonic fermentation in epidemiologic studies: circadian patterns of excretion. Environ. Health Perspect. 98, 199-202 (1992).
125. Socolowsky S, Hohne C, Sandow D. The direct detection of volatile fatty acids by gas chromatography in microbiological diagnosis. Z. Med. Lab Diagn. 31, 445-452 (1990).
126. Syhre M, Chambers ST. The scent of Mycobacterium tuberculosis. Tuberculosis 88, 317-323 (2008).
127. Syhre M, Manning L, Phuanukoonnon S, Harino P, Chambers ST. The scent of Mycobacterium tuberculosis - part II breath. Tuberculosis 89, 263-266 (2009).
128. Phillips M, Basa-Dalay V, Bothamley G et al. Breath biomarkers of active pulmonary tuberculosis. Tuberculosis 90, 145-151 (2010).
129. Hayward NJ. Head-space/gas-liquid chromatography in clinical microbiology with special reference to the laboratory diagnosis of urinary tract infections. In: Gas Chromatography/Mass Spectrometry: Applications in Microbiology. Odham G, Larsson L, Mardh PA (Eds). Plenum Press, NY, USA, 237-255 (1984).
130. Hayward NJ, Jeavons TH. Assessment of technique for rapid detection of Escherichia coli and proteus species in urine by head- space gas-liquid chromatography. J. Clin. Microbiol. 6, 202-208 (1977).
131. Shuster G, Gallimidi Z, Reiss AH et al. Classification of breast cancer precursors through exhaled breath. Breast Cancer Res. Treat. 126(3), 791-796 (2011).
132. Santonico M, Pittia P, Pennazza G et al. Study of the aroma of artificially flavoured custards by chemical sensor array fingerprinting. Sens. Actuat. B 133, 345-351 (2008).
133. Carey JR, Suslick KS, Hulkower KI et al. Rapid identification of bacteria with a disposable colorimetric sensing array. J. Am. Chem. Soc. 133(19), 7571-7576 (2011).
134. Dragonieri S, Annema JT, Schot R et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 64, 166-170 (2009).
135. Lazar Z, Fens N, van der Maten J et al. Electronic nose breathprints are independent of acute changes in airway caliber in asthma. Sensors 10, 9127-9138 (2010).
136. Fens N, Douma RA, Sterk PJ, Kamphuisen PW. Breathomics as a diagnostic tool for pulmonary embolism. J. Thromb. Haemost. 8(12), 2831-2833 (2010).
137. Greulich T, Hattesohl A, Grabisch A et al. Detection of obstructive sleep apnoea by an electronic nose. Eur. Respir. J. doi:10.1183/09031936.00091712 (2012) (Epub ahead of print).
138. Biller H, Holz O, Windt H et al. Breath profiles by electronic nose correlate with systemic markers but not ozone response. Respir. Med. 105(9), 1352-1363 (2011).